[Novel strategies of ovarian cancer treatment]

Katarzyna Duda1, Hanna Cholewa1, Krzysztof Łabuzek1

  • 1Silesian University of Medicine in Katowice, Poland: Department of Internal Diseases and Clinical Pharmacology.

Insights

Ovarian cancer is a deadly gynecological malignancy often detected late due to vague symptoms. Novel therapies targeting tumor microenvironment and drug repositioning, like metformin, offer hope for improved treatment outcomes.

Area of Science:

  • Gynecologic Oncology
  • Medical Research

Context:

  • Ovarian cancer is the leading cause of gynecological cancer death.
  • Late-stage diagnosis is common due to non-specific symptoms and lack of screening.
  • Current treatments are often insufficient for recurrent disease.

Purpose:

  • To explore novel therapeutic strategies for ovarian cancer.
  • To investigate approaches targeting the tumor microenvironment.
  • To evaluate the potential of drug repositioning for ovarian cancer treatment.

Summary:

  • Research focuses on new ovarian cancer treatments, including inhibiting angiogenesis and targeting cancer stem cells.
  • Inhibiting poly(ADP-ribose) polymerase (PARP) and class I histone deacetylase are promising avenues.
  • Drug repositioning, exemplified by the antidiabetic agent metformin, is being explored.

Impact:

  • Advances in understanding and treating ovarian cancer are crucial.
  • Novel therapeutic approaches aim to improve outcomes for patients with this lethal disease.
  • Continued scientific progress offers hope for more effective ovarian cancer management.

Related Concept Videos

Cancer Therapies02:49

Cancer Therapies

Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
10.6K
Treatment Resistant Cancers02:56

Treatment Resistant Cancers

Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.9K
Treatment Resistent Cancers02:56

Treatment Resistent Cancers

1.5K
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
9.1K
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

1.8K